Novel treatment modalities in erectile dysfunction
The objective of this recording is to provide an update on new modalities of ED-treatment such as stem cell therapy, extracorporeal shock wave treatment, and platelet-rich plasma usage.
|Organiser||European School of Urology (ESU)|
|Duration||Approx. 70 minutes|
Considering that a subpopulation of men with erectile dysfunction (ED) is unresponsive to Phosphodiesterase-5 (PDE5) inhibitors, it appears that novel modes of treatments for ED are of paramount importance.
This recorded webinar will answer questions raising theses and antitheses concerning their efficiency, safety, or genetic, and epigenetic risks.
Furthermore, the experts will discuss the current EAU Guidelines and their underlying rationale for the pharmaceutical or surgical treatment of Peyronie’s disease.
Prof. Dr. J. Rassweiler (DE)
Prof. N. Sofikitis (GR)
Dr. M. Benyó (HU)
Prof. A. Kadioglu (TR)
This recording is brought to you in collaboration with ESUO-ESAU.
The recording of this webinar is not EU-ACME accredited.
Missed the live session? Earn 1 CME point by completing our online e-course at:
Don't miss this opportunity!
Contact our organiser
European School of Urology (ESU)